Skip to content

Cast or Functional Ankle Orthosis After Ankle Fracture Surgery

Postoperative Care After Operatively Treated Ankle Fractures With Cast or Functional Ankle Orthosis. A 2-year, Prospective, Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06559111
Enrollment
134
Registered
2024-08-19
Start date
2005-12-01
Completion date
2012-03-16
Last updated
2025-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Fracture, Postoperative Treatment

Brief summary

The goal of this randomized clinical trial was to compare the effect of 6-week casting versus 2-week casting followed by 4-week ankle bracing in adult patients with surgically treated ankle fractures. The primary outcome measures used were the functional results 3 months after surgery evaluated using two functional outcome measures (Olerud and Molander score and Kaikkonen score) and the patient return to work. In the casting group, the traditional plaster was changed to a fiberglass one at 2 weeks and the cast treatment continued until 6 weeks. In the functional treatment group, the traditional plaster cast was changed to an reusable semi-rigid plastic orthosis (Aircast) at 2 weeks after surgery and its use was continued as an ankle support for up to 6 weeks. Follow-ups including subjective and objective evaluations were at 2, 6, 12 and 52 weeks and at 2 years postoperatively.

Interventions

DEVICE2-week casting followed by 4-week bracing

Participants in the bracing group had a cast for 2 weeks after the surgery followed by ankle brace for 4 weeks.

DEVICE6-week casting

Participants in the casting group had a cast for 6 weeks after the surgery.

Sponsors

Tampere University Hospital
CollaboratorOTHER
Töölö Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

Randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Weber A or B type ankle fracture * uni-, bi- or trimalleolar injury and/or fibular displacement of \>2 mm in any plane on the radiographs

Exclusion criteria

* Weber C injury necessitating syndesmotic fixation * Pilon injury * Inadequate co-operation * Other severe concomitant injuries

Design outcomes

Primary

MeasureTime frameDescription
Olerud-Molander score3 months and 24 monthsPatient-reported outcome measure, 0-100 points, higher points indicating better result.

Secondary

MeasureTime frameDescription
Ankle active plantarflexion6 weeks, 3, 12, and 24 monthsDegrees compared to unaffected side
Return-to-workWithin 24 monthsDays after the injury
Olerud-Molander score6 weeks and 12 monthsPatient-reported outcome measure, 0-100 points, higher points indicating better result.
Kaikkonen score6 weeks, 3, 12, and 24 monthsPatient-reported outcome measure, 0-100 points, higher points indicating better result.
Swelling of the ankle6 weeks, 3, 12, and 24 monthsCircumference in millimetres compared to unaffected side
Atrophy of the calf muscles6 weeks, 3, 12, and 24 monthsCircumference in millimetres compared to unaffected side
Ankle active dorsiflexion6 weeks, 3, 12, and 24 monthsDegrees compared to unaffected side
Subjective symptoms and return to activities2 and 6 weeks; 3, 12, and 24 monthsThe patients were questioned about the subjective symptoms (pain, swelling, stiffness and giving way) and about the compliance of using the cast or brace. In addition the patients were asked about the length of their inability to work and participate in the daily activities and/or sports at the preinjury level.
Visual Analog Scale for Pain6 weeks, 3, 12, and 24 months0-10, higher score indicating more pain.

Other

MeasureTime frameDescription
Complications2 and 6 weeks; 3, 12, and 24 monthsInfection, loss of reduction, implant loosening, deep vein thrombosis

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026